Reiner Uhl - Concepedia

Concepedia

Author

Reiner Uhl

Mundipharma (Germany)

Also Known As

R Uhl, R. Uhl, Reiner Uhl

9

Publications

1.2K

Citations

7

H-Index

17

Concepts

All Affiliations

Mundipharma (Germany)Mundipharma (United Kingdom)Research Institute of Human Morphology Witten/Herdecke University Goethe University Frankfurt

RU

About

Reiner Uhl is an author at Mundipharma (Germany) specializing in pharmacology, medicine, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	347
2	Pharmacology	2	2	347
3	Engineering	1	1	298
4	Health Sciences	1	1	49
5	Biomedical Engineering	1	1	298

Reiner Uhl

×

7

Publications

1.2K

Citations

7

H-Index

	Year	Citations
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles Sebastian C.J. Steiniger, Jörg Kreuter, A. S. Khalansky, International Journal of Cancer	2004	434
Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants Boris Petri, Alexander Bootz, A. S. Khalansky, Journal of Controlled Release NanoparticlesNanomedicineNeuro-oncologyMedicinal ChemistrySurfactant-coated Poly	2006	298
Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial O. Löwenstein, Petra Leyendecker, Michael Hopp, Expert Opinion on Pharmacotherapy	2009	159
High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement Cornelius Keyl, Reiner Uhl, Friedhelm Beyersdorf, European Journal of Cardio-Thoracic Surgery	2011	111
Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain Andreas Sandner‐Kiesling, Petra Leyendecker, Michael Hopp, International Journal of Clinical Practice	2010	100
Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers Kevin J. Smith, Michael Hopp, Gill Mundin, Clinical Therapeutics Healthy Adult VolunteersMultiple-dose Pharmacokinetic EvaluationAddictionPain MedicineMedicine	2008	49
Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis W. Dunlop, Reiner Uhl, Iftekhar Khan, Journal of Medical Economics	2012	46

Page 1